Medical technology company Trivitron Healthcare has launched two new high-performance liquid chromatography analysers NANO H5 & NANO H110 for detection of HbA1c and Hb variant.
Glycated haemoglobin or HbA1c is a form of haemoglobin that is chemically linked to a sugar, mostly monosaccharides, including glucose, galactose and fructose. HbA1c test gives a measure of how well controlled your blood sugar has been over a period of about 3 months. It essentially gives a good idea of how high or low, on average, your blood glucose levels have been.
The newly developed analysers can detect HbA1c in less than 3 minutes. These HPLC based HbA1c analysers will be used for monitoring diabetes, thalassemia and haemoglobin variants.
NANO H5, is a compact, automated HPLC analyser that uses ion exchange liquid chromatography for the quantitative determination of the glycated haemoglobin in human whole blood with a processing time of 130 seconds that will expedite the laboratory TAT. The fully automated analyser promises to process 5 samples at a time, says the company.
NANO H110, is a compact, automated HPLC analyser that has a dual test mode for HbA1c test and Hb variant detection. It has some advanced facilities such as barcode scanner and cap piercing with a high sample loading capacity of 110 samples at a time which make it suitable for laboratories with medium to large workloads. Laboratory testing for haemoglobin variants is a measure to evaluate the haemoglobin inside the RBCs and analyse relevant gene mutations or deletions.
“Keeping in mind the increasing concern for the management of diabetes and the growing demand for accurate measurement of HbA1c level, we are delighted to announce the launch of HPLC based HbA1c analysers – NANO H5 & NANO H110, that are compact and designed for precision,” said Rajesh Patel, Chief Executive Officer (IVD Business), Trivitron Healthcare during the press release.